Page 37 - Read Online

Oquendo et al. J Transl Genet Genom 2021;5:89-111 https://dx.doi.org/10.20517/jtgg.2021.04 Page 109

Lymphoma. Sci Rep 2019;9:10444. DOI PubMed PMC
54. Kiel MJ, Velusamy T, Betz BL, et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal
zone lymphoma. J Exp Med 2012;209:1553-65. DOI PubMed PMC
55. Luijten MNH, Lee JXT, Crasta KC. Mutational game changer: Chromothripsis and its emerging relevance to cancer. Mutat Res
2018;777:29-51. DOI PubMed
56. Parry M, Rose-Zerilli MJ, Gibson J, et al. Whole exome sequencing identifies novel recurrently mutated genes in patients with
splenic marginal zone lymphoma. PLoS One 2013;8:e83244. DOI PubMed PMC
57. Rossi D, Trifonov V, Fangazio M, et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other
pathways regulating marginal zone development. J Exp Med 2012;209:1537-51. DOI PubMed PMC
58. Campos-Martín Y, Martínez N, Martínez-López A, et al. Clinical and diagnostic relevance of NOTCH2-and KLF2-mutations in
splenic marginal zone lymphoma. Haematologica 2017;102:e310-2. DOI PubMed PMC
59. Jallades L, Baseggio L, Sujobert P, et al. Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2,
TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica 2017;102:1758-66. DOI
PubMed PMC
60. Feinberg MW, Lin Z, Fisch S, Jain MK. An emerging role for Krüppel-like factors in vascular biology. Trends Cardiovasc Med
2004;14:241-6. DOI PubMed
61. Dang DT, Pevsner J, Yang VW. The biology of the mammalian Krüppel-like family of transcription factors. Int J Biochem Cell Biol
2000;32:1103-21. DOI PubMed PMC
62. Hart GT, Wang X, Hogquist KA, Jameson SC. Krüppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and
trafficking molecule expression. Proc Natl Acad Sci U S A 2011;108:716-21. DOI PubMed PMC
63. Winkelmann R, Sandrock L, Porstner M, et al. B cell homeostasis and plasma cell homing controlled by Krüppel-like factor 2. Proc
Natl Acad Sci U S A 2011;108:710-5. DOI PubMed PMC
64. Hoek KL, Gordy LE, Collins PL, et al. Follicular B cell trafficking within the spleen actively restricts humoral immune responses.
Immunity 2010;33:254-65. DOI PubMed PMC
65. Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human
genome. Nucleic Acids Res 2019;47:D886-94. DOI PubMed PMC
66. Tanigaki K, Han H, Yamamoto N, et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat
Immunol 2002;3:443-50. DOI PubMed
67. Saito T, Chiba S, Ichikawa M, et al. Notch2 Is Preferentially Expressed in Mature B Cells and Indispensable for Marginal Zone B
Lineage Development. Immunity 2003;18:675-85. DOI PubMed
68. Arruga F, Vaisitti T, Deaglio S. The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies. Front Oncol 2018;8:550.
DOI PubMed PMC
69. Moran ST, Cariappa A, Liu H, et al. Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B
lymphocytes. J Immunol 2007;179:195-200. DOI PubMed
70. Kopan R. Notch signaling. Cold Spring Harb Perspect Biol 2012;4:a011213. DOI PubMed PMC
71. Radtke F, Wilson A, MacDonald HR. Notch signaling in T- and B-cell development. Curr Opin Immunol 2004;16:174-9. DOI
PubMed
72. Martínez N, Almaraz C, Vaqué JP, et al. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes
involved in marginal zone differentiation. Leukemia 2014;28:1334-40. DOI PubMed
73. Shanmugam V, Craig JW, Hilton LK, et al. Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for
Notch signaling in B-cell tumors. Blood Adv 2021;5:71-83. DOI PubMed PMC
74. Hampel F, Ehrenberg S, Hojer C, et al. CD19-independent instruction of murine marginal zone B-cell development by constitutive
Notch2 signaling. Blood 2011;118:6321-31. DOI PubMed
75. Fabbri G, Holmes AB, Viganotti M, et al. Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia. Proc Natl
Acad Sci U S A 2017;114:E2911-9. DOI PubMed PMC
76. Kim MP, Lozano G. Mutant p53 partners in crime. Cell Death Differ 2018;25:161-8. DOI PubMed PMC
77. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 2009;9:767-77. DOI
PubMed
78. Spina V, Rossi D. NF-κB deregulation in splenic marginal zone lymphoma. Semin Cancer Biol 2016;39:61-7. DOI PubMed
79. Lim KH, Yang Y, Staudt LM. Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies. Immunol
Rev 2012;246:359-78. DOI PubMed PMC
80. Yan Q, Huang Y, Watkins AJ, et al. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic
marginal zone lymphomas. Haematologica 2012;97:595-8. DOI PubMed PMC
81. Pillonel V, Juskevicius D, Ng CKY, et al. High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF
mutations. Leukemia 2018;32:2412-26. DOI PubMed PMC
82. Ngo VN, Young RM, Schmitz R, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011;470:115-9. DOI
PubMed PMC
83. Lunning MA, Green MR. Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas. Blood
Cancer J 2015;5:e361. DOI PubMed PMC
84. Spina V, Khiabanian H, Messina M, et al. The genetics of nodal marginal zone lymphoma. Blood 2016;128:1362-73. DOI PubMed
PMC